Jason Wittes
Stock Analyst at Roth Capital
(2.81)
# 1,698
Out of 5,131 analysts
61
Total ratings
50.94%
Success rate
6.64%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals | Initiates: Buy | $40 | $11.38 | +251.49% | 1 | Sep 4, 2025 | |
| SYK Stryker | Maintains: Buy | $405 → $456 | $361.37 | +26.19% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $1.84 | +769.57% | 2 | Mar 21, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $4.20 | +280.95% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $15.26 | +44.17% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $97.90 | -26.46% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.89 | +86.92% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $91.72 | +25.38% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $13.88 | +159.37% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $7.74 | +42.12% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.96 | +941.67% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $83.91 | +19.18% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.56 | +95.31% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.87 | +932.58% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $26.95 | +178.29% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $17.59 | +25.07% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $91.45 | +31.22% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $132.27 | +55.74% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $209.42 | -30.76% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $24.19 | -37.99% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $14.18 | +1,310.44% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $27.72 | -6.20% | 1 | Feb 22, 2017 |
ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $11.38
Upside: +251.49%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $361.37
Upside: +26.19%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $1.84
Upside: +769.57%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $4.20
Upside: +280.95%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $15.26
Upside: +44.17%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $97.90
Upside: -26.46%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.89
Upside: +86.92%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $91.72
Upside: +25.38%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $13.88
Upside: +159.37%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.74
Upside: +42.12%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $0.96
Upside: +941.67%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $83.91
Upside: +19.18%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.56
Upside: +95.31%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $0.87
Upside: +932.58%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $26.95
Upside: +178.29%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $17.59
Upside: +25.07%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $91.45
Upside: +31.22%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $132.27
Upside: +55.74%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $209.42
Upside: -30.76%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $24.19
Upside: -37.99%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $14.18
Upside: +1,310.44%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $27.72
Upside: -6.20%